AstraZeneca PLC Board composition, processes & responsibilities
The Board comprises three Executive Directors (two from April 2009 when John Patterson’s retirement takes effect) and 11 Non-Executive Directors. The membership of the Board at 31 December 2008, and information about individual Directors is contained in the Board of Directors section.
BOARD AND SENIOR MANAGEMENT
1 As determined by the Board in accordance with the UK Combined Code
All Directors are collectively responsible for the success of the Company. The Non-Executive Directors have a responsibility to bring independent, objective judgement to bear on Board decisions, which includes constructively challenging management and helping to develop the Company’s strategy as well as scrutinising the performance of management. The Non-Executive Directors also have various responsibilities concerning the integrity of financial information, internal controls and risk management.
At the end of every Board meeting, the Company’s Non-Executive Directors meet without the Executive Directors present in order to review and discuss any matters that have arisen during the meeting and/or such other matters as may appear to the Non-Executive Directors to be relevant to them in properly discharging their duties independently. To ensure the Board has good visibility of the key operating decisions of the business, members of the SET routinely attend Board meetings on a rotational basis and the Board regularly meets and consults other senior employees throughout the year.
QUICK LINKS
DOWNLOAD REPORT
GLOSSARY
Abbreviations/expressions and their meanings, when used on this website
CORPORATE RESPONSIBILITY
Find out more about our commitment to responsible business
FEEDBACK
Your opinions and comments are very important to us
Our report is available to download in